The decision to quit smoking is a big step to improving your health. It is never too late to quit and the benefits include a reduction in cancer, heart and lung disease, and improved quality of life. When attempting to quit smoking, both counseling and smoking cessation...
Ticagrelor (Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor used after a heart attack to prevent clots from forming and causing further heart attacks. At this moment, there no clear evidence for the use of pharmacogenetics for ticagrelor. PharmGKB, a NIH-funded database that curates knowledge...
TreatGx is a precision prescribing software (medication decision support system) that personalizes prescriptions to help reduce the risk of adverse drug reactions, increase medication efficacy and reduce healthcare costs. TreatGx goes beyond the individual’s genetic code and enables precision prescribing by detecting complex interactions including...
PharmGKB is a publicly available internet research tool that provides information about how genetic variation among individuals contributes to differences in reactions to drugs. Developed by Stanford University and funded by the National Institutes of Health (NIH), PharmGKB is the largest pharmacogenetic database. The information in...
